Exchange: NYSE·Updated 03:29 PM EDT
Latest Earnings Results: Q2 '26

Reported: Jul 29

Estimated EPS

$0.05

Reported EPS

$0.02

Surprise

-61.35%

Estimated Rev

$4.02B

Reported Rev

$4.14B

Surprise

+3.02%

$TEVA Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.49 down -296.00% YoY • Reported revenue of $4.14B down -0.81% YoY • Teva Pharmaceutical Industries Ltd. expects 2026 revenue of $16.5-$16.85 billion, non-GAAP operating income of $3.8-$4.0 billion, and non-GAAP diluted EPS of $1.91-$2.11, while maintaining its free cash flow outlook.

Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

Investor Presentation10-Q

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '26
$0.71
--
--
N/A
Q2 '26
$0.05
$0.02
-61.35%
MISSED
Q1 '26
$0.46
$0.53
15.81%
BEAT
Q4 '25
$0.64
$0.96
49.71%
BEAT
Q3 '25
$0.68
$0.78
15.54%
BEAT

Advertisement|Remove ads.